Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02813590

Ascitic Fluid Microbiome in Liver Cirrhosis

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Ascitic fluid microbiome is going to be investigated in this study by using internal transcripted spacer (ITS) and 16S ribosomal RNA (rRNA) polymerase chain reaction (PCR) and sequencing as conventional culture methods are lacking sensitivity regarding diagnosis of spontaneous bacterial peritonitis (SBP). All patients with routinely performed ascitic fluid puncture and underlying liver cirrhosis are included in this study. Next generation sequencing (NGS) in ascitic fluid, skin swaps from puncture side and stool samples as well as conventional culture methods are performed to investigate the difference in the microbiome between patients with and without SBP.

Conditions

Interventions

TypeNameDescription
OTHERAscitic fluid puncture
OTHERSkin swaps from puncture side
OTHERStool samples

Timeline

Start date
2016-06-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2016-06-27
Last updated
2024-03-15

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT02813590. Inclusion in this directory is not an endorsement.

Ascitic Fluid Microbiome in Liver Cirrhosis (NCT02813590) · Clinical Trials Directory